JP5456222B2 - Ｉｌ−１関連ポリペプチド - Google Patents

Ｉｌ−１関連ポリペプチド Download PDF

Info

Publication number
JP5456222B2
JP5456222B2 JP2000591188A JP2000591188A JP5456222B2 JP 5456222 B2 JP5456222 B2 JP 5456222B2 JP 2000591188 A JP2000591188 A JP 2000591188A JP 2000591188 A JP2000591188 A JP 2000591188A JP 5456222 B2 JP5456222 B2 JP 5456222B2
Authority
JP
Japan
Prior art keywords
amino acid
hil
polypeptide
seq
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000591188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533122A (ja
JP2002533122A5 (enExample
Inventor
ゴッダード，オードリ
パン，ジェームス
Original Assignee
ジェネンテック， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェネンテック， インコーポレイテッド filed Critical ジェネンテック， インコーポレイテッド
Publication of JP2002533122A publication Critical patent/JP2002533122A/ja
Publication of JP2002533122A5 publication Critical patent/JP2002533122A5/ja
Application granted granted Critical
Publication of JP5456222B2 publication Critical patent/JP5456222B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000591188A 1998-12-23 1999-12-22 Ｉｌ−１関連ポリペプチド Expired - Lifetime JP5456222B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11343098P 1998-12-23 1998-12-23
US60/113,430 1998-12-23
US11684399P 1999-01-22 1999-01-22
US60/116,843 1999-01-22
US12912299P 1999-04-13 1999-04-13
US60/129,122 1999-04-13
PCT/US1999/030720 WO2000039297A2 (en) 1998-12-23 1999-12-22 Il-1 related polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011001700A Division JP2011155971A (ja) 1998-12-23 2011-01-07 Ｉｌ−１関連ポリペプチド

Publications (3)

Publication Number Publication Date
JP2002533122A JP2002533122A (ja) 2002-10-08
JP2002533122A5 JP2002533122A5 (enExample) 2007-06-21
JP5456222B2 true JP5456222B2 (ja) 2014-03-26

Family

ID=27381318

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000591188A Expired - Lifetime JP5456222B2 (ja) 1998-12-23 1999-12-22 Ｉｌ−１関連ポリペプチド
JP2011001700A Pending JP2011155971A (ja) 1998-12-23 2011-01-07 Ｉｌ−１関連ポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011001700A Pending JP2011155971A (ja) 1998-12-23 2011-01-07 Ｉｌ−１関連ポリペプチド

Country Status (7)

Country Link
US (4) US20070042466A1 (enExample)
EP (3) EP1141299A2 (enExample)
JP (2) JP5456222B2 (enExample)
AU (1) AU778759B2 (enExample)
CA (1) CA2354027A1 (enExample)
IL (1) IL143593A0 (enExample)
WO (1) WO2000039297A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ505881A (en) 1998-01-09 2003-05-30 Immunex Corp IL-1 delta DNA and polypeptides
US6541623B1 (en) * 1998-04-03 2003-04-01 Hyseq, Inc. Interleukin—1 receptor antagonist and uses thereof
US7033783B2 (en) 1998-12-14 2006-04-25 Immunex Corp. Polynucleotide encoding IL-1 zeta polypeptide
WO2001005974A2 (en) * 1999-07-16 2001-01-25 Interleukin Genetics, Inc. The il-1l1 gene and polypeptide products
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
EP2500438A3 (en) * 2002-09-25 2012-11-28 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
CA3221001A1 (en) 2015-07-06 2017-01-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
AR123405A1 (es) 2018-12-21 2022-11-30 23Andme Inc Anticuerpos anti-il-36 y métodos de uso de estos

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
JPS63502716A (ja) 1986-03-07 1988-10-13 マサチューセッツ・インステチュート・オブ・テクノロジー 糖タンパク安定性の強化方法
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5169770A (en) 1987-12-21 1992-12-08 The University Of Toledo Agrobacterium mediated transformation of germinating plant seeds
AU4005289A (en) 1988-08-25 1990-03-01 Smithkline Beecham Corporation Recombinant saccharomyces
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
AU641673B2 (en) 1989-06-29 1993-09-30 Medarex, Inc. Bispecific reagents for aids therapy
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
CA2089661C (en) 1990-08-29 2007-04-03 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
US5206161A (en) 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
JPH06507398A (ja) 1991-05-14 1994-08-25 リプリジェン　コーポレーション Ｈｉｖ感染治療のための異種複合抗体
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
WO1995010298A1 (en) 1993-10-12 1995-04-20 Mary Lake Polan Method of contraception
US5863769A (en) * 1997-01-28 1999-01-26 Smithkline Beecham Corporation DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
CA2287254A1 (en) * 1997-04-21 1998-10-29 Schering Corporation Mammalian cytokines; related reagents and methods
WO1999006426A1 (en) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Novel molecules of the tango-77 related protein family and uses thereof
NZ505881A (en) * 1998-01-09 2003-05-30 Immunex Corp IL-1 delta DNA and polypeptides
WO1999051744A2 (en) * 1998-04-03 1999-10-14 Hyseq, Inc. A interleukin-1 receptor antagonist and uses thereof
US6294655B1 (en) * 1998-04-03 2001-09-25 Hyseq, Inc. Anti-interleukin-1 receptor antagonist antibodies and uses thereof
AU5772299A (en) 1998-08-07 2000-02-28 Millennium Pharmaceuticals, Inc. Novel molecules of the tango-93-related protein family and uses thereof
AU6386399A (en) * 1998-09-18 2000-04-10 Schering Corporation Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
US6680380B1 (en) * 1998-09-18 2004-01-20 Schering Corporation Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods
AU6296899A (en) * 1998-10-08 2000-04-26 Zymogenetics Inc. Interleukin-1 homolog
DK1129194T3 (da) * 1998-10-27 2006-01-23 Zymogenetics Inc Homologt interleukin-1-ZIL1A4
US7033783B2 (en) * 1998-12-14 2006-04-25 Immunex Corp. Polynucleotide encoding IL-1 zeta polypeptide
ATE428726T1 (de) * 1998-12-14 2009-05-15 Immunex Corp Xrec2 dns und polypeptide
NZ527292A (en) * 1999-03-23 2005-03-24 Genentech Inc Secreted and transmembrane polypeptides PRO1484 and nucleic acids encoding the same, with homology to an adipocyte complement-related protein
EP1233977A1 (en) 1999-12-01 2002-08-28 SmithKline Beecham Corporation Interleukin-1 homologue, mat il-1h4
CA2395417A1 (en) 1999-12-10 2001-06-14 Amgen Inc. Interleukin-1 receptor antagonist-related molecules and uses thereof

Also Published As

Publication number Publication date
US8628777B2 (en) 2014-01-14
US20070042466A1 (en) 2007-02-22
CA2354027A1 (en) 2000-07-06
WO2000039297A3 (en) 2001-02-22
EP1141299A2 (en) 2001-10-10
EP2319929A1 (en) 2011-05-11
WO2000039297A2 (en) 2000-07-06
AU2593500A (en) 2000-07-31
AU778759B2 (en) 2004-12-16
US7951916B2 (en) 2011-05-31
US20090269811A1 (en) 2009-10-29
JP2002533122A (ja) 2002-10-08
EP2330198A1 (en) 2011-06-08
IL143593A0 (en) 2002-04-21
US20090304701A1 (en) 2009-12-10
US20090270595A1 (en) 2009-10-29
JP2011155971A (ja) 2011-08-18

Similar Documents

Publication Publication Date Title
JP3577586B2 (ja) Ｉｌ−１７相同的ポリペプチドとその治療用途
US6299877B1 (en) Type I interferons
JP2011155971A (ja) Ｉｌ−１関連ポリペプチド
JP2011019519A (ja) インターロイキン−２２ポリペプチド、それをコードする核酸並びに膵臓疾患の治療方法
JP2002533122A5 (enExample)
JP2010046065A (ja) インターロイキン−８と相同なポリペプチドとその治療用途
JP4931310B2 (ja) ヘルパーｔ細胞性疾患の治療のためのｔ細胞分化の調節
JP2009219492A (ja) Ｇｄｎｆｒと配列類似性を有する新規ポリペプチド及びこれをコードする核酸
JP2005519590A (ja) 免疫関連疾患の治療のための組成物及び方法
KR20010085816A (ko) 면역 관련 질환 치료용 조성물 및 치료 방법
JP3886899B2 (ja) インターロイキン−２２ポリペプチド、それをコードする核酸並びに膵臓疾患の治療方法
JP2007537691A (ja) 免疫不全の治療のための新規組成物と方法
JP4166254B2 (ja) ボールカインポリペプチド及び核酸
US6967245B2 (en) Ucp5
US7342102B2 (en) Uncoupling protein 5 (UCP5)
JP2005502317A (ja) ボールカインポリペプチド及び核酸
US20040215007A1 (en) Novel secreted proteins and their uses
EP1115863A1 (en) Ucp4
JP2002533062A5 (enExample)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061213

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20070426

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100209

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100310

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100317

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100409

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100510

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110107

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121002

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121009

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121105

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121203

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131114

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140108

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5456222

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term